The contents of this website are intended for US healthcare professionals only.
This site will be intermittently unavailable for routine maintenance starting on Friday, September 20th at 9pm ET and lasting through Sunday September 22nd.
Indication
BIMZELX® (bimekizumab-bkzx) is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
